Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Klein P, et al. A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures. Epilepsia. 2015 Dec;56(12):1890-98.
Sehn LH, et al. GADOLIN: Primary results from a phase III study of obinutuzumab plus bendamustine compared with bendamustine alone in patients with rituximab-refractory indolent non-Hodgkin lymphoma (abstract LBA8502). Presented at 2015 ASCO Annual Meeting. May 29-June 2, 2015. Chicago, IL. http://meetinglibrary.asco.org/content/147837-156
Yao JC, et al. Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. Lancet. 2015 Dec 15.
Poordad F, et al. Daclatasvir with sofosbuvir and ribavirin for HCV infection with advanced cirrhosis or post-liver transplant recurrence. Hepatology. 2016 Jan 11.
Wyles DL, et al. Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1. N Engl J Med. 2015 Aug 20;373(8):714-25.
A special meeting review edition: Advances in the treatment of hepatitis C virus infection from EASL 2015. Gastroenterol Hepatol (N Y). 2015 Jun; 11(6 Suppl 3): 1–23. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617178
Previous
